Whither Type 1 Diabetes?
N Engl J Med
.
2020 Nov 19;383(21):2078-2079.
doi: 10.1056/NEJMe2030472.
Author
Domenico Accili
1
Affiliation
1
From the Department of Medicine and Berrie Diabetes Center, Vagelos College of Physicians and Surgeons, Columbia University, New York.
PMID:
33207099
PMCID:
PMC8996297
DOI:
10.1056/NEJMe2030472
No abstract available
Publication types
Editorial
Comment
MeSH terms
Adolescent
Antibodies, Monoclonal
Diabetes Mellitus, Type 1*
Diabetes Mellitus, Type 2*
Humans
Substances
Antibodies, Monoclonal
golimumab
Grants and funding
R37 DK058282/DK/NIDDK NIH HHS/United States
R01 DK057539/DK/NIDDK NIH HHS/United States
P01 HL087123/HL/NHLBI NIH HHS/United States
P30 DK063608/DK/NIDDK NIH HHS/United States
R01 DK064819/DK/NIDDK NIH HHS/United States
R01 DK058282/DK/NIDDK NIH HHS/United States